LONNEL COATS - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Lonnel Coats
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Transactions value $
$-160,792
Form type
4
Filing time
29 Feb 2024, 16:26:53 UTC
Previous filing
12 Feb 2024
Next filing
14 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +33,333 +3.65% 947,692 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +91,364 +9.64% 1,039,056 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +120,383 +11.6% 1,159,439 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $-160,792 -61,371 -5.29% $2.62 1,098,068 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -33,333 -100% 0 28 Feb 2024 Common Stock 33,333 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -91,364 -50% 91,363 28 Feb 2024 Common Stock 91,364 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -120,383 -33.3% 240,767 28 Feb 2024 Common Stock 120,383 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.